Ballentine Partners, LLC Dr Reddys Laboratories LTD Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q3 2024
A detailed history of Ballentine Partners, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ballentine Partners, LLC holds 15,452 shares of RDY stock, worth $219,418. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,452
Previous 13,213
16.95%
Holding current value
$219,418
Previous $1.01 Million
21.97%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding RDY
# of Institutions
244Shares Held
23.2MCall Options Held
12.7KPut Options Held
6.1K-
Morgan Stanley New York, NY2.24MShares$31.8 Million0.01% of portfolio
-
Robeco Institutional Asset Management B.V.2.07MShares$29.3 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$28.3 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$27.7 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$25.6 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.36B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...